Latest news and press releases about Femasys Inc. (FEMY): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
Price
| Price | $2.54 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AIMD · APLM · BCTX · COCH · CRIS · DARE · EKSO
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of FEMY: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks